Maximizing outcomes in genitourinary cancers across the treatment continuum.

about

Maximizing outcomes in genitourinary cancers across the treatment continuum.

Item

http://www.wikidata.org/entity/Q50246373

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Maximizing outcomes in genitourinary cancers across the treatment continuum.

@en

Maximizing outcomes in genitourinary cancers across the treatment continuum.

@nl

type

Item

label

Maximizing outcomes in genitourinary cancers across the treatment continuum.

@en

Maximizing outcomes in genitourinary cancers across the treatment continuum.

@nl

prefLabel

Maximizing outcomes in genitourinary cancers across the treatment continuum.

@en

Maximizing outcomes in genitourinary cancers across the treatment continuum.

@nl

P1476

Maximizing outcomes in genitourinary cancers across the treatment continuum.

@en

P2093

Alexandre Zlotta

http://www.w3.org/2001/XMLSchema#string

Bertrand Tombal

http://www.w3.org/2001/XMLSchema#string

Christopher J Logothetis

http://www.w3.org/2001/XMLSchema#string

Joaquim Bellmunt

http://www.w3.org/2001/XMLSchema#string

John M Fitzpatrick

http://www.w3.org/2001/XMLSchema#string

Judd W Moul

http://www.w3.org/2001/XMLSchema#string

Neil E Fleshner

http://www.w3.org/2001/XMLSchema#string

Robert Dreicer

http://www.w3.org/2001/XMLSchema#string

P2860

Mortality results from a randomized prostate-cancer screening trial

Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial

Cancer statistics, 2009

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

Screening and prostate-cancer mortality in a randomized European study

Effect of dutasteride on the risk of prostate cancer.

Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration.

Prognostic factors in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: multivariate analysis of data from four randomized CUETO trials.

Chemotherapy with an every-2-week regimen of gemcitabine and paclitaxel in patients with transitional cell carcinoma who have received prior cisplatin-based therapy.

P304

1-12

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1464-410X.2010.10035.X

http://www.w3.org/2001/XMLSchema#string

P478

107 Suppl 2

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21382149

http://www.w3.org/2001/XMLSchema#string